Found: 74
Select item for more details and to access through your institution.
Management of good risk germ-cell tumours.
- Published in:
- BJU International, 2009, v. 104, n. 9B, p. 1387, doi. 10.1111/j.1464-410X.2009.08864.x
- By:
- Publication type:
- Article
Chemotherapy in hormone-refractory prostate cancer.
- Published in:
- BJU International, 2008, v. 101, p. 11, doi. 10.1111/j.1464-410X.2007.07485.x
- By:
- Publication type:
- Article
Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37647-x
- By:
- Publication type:
- Article
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y
- By:
- Publication type:
- Article
Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1287, doi. 10.1093/jjco/hyab028
- By:
- Publication type:
- Article
Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. 43, doi. 10.1016/j.clgc.2021.10.008
- By:
- Publication type:
- Article
A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 6009, doi. 10.3390/ijms24066009
- By:
- Publication type:
- Article
Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y
- By:
- Publication type:
- Article
Letters and Corrections.
- Published in:
- 1990
- By:
- Publication type:
- Letter
Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221100022
- By:
- Publication type:
- Article
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Small cell carcinoma of the cervix with inappropriate antidiuretic hormone secretion. Case report.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 1990, v. 97, n. 7, p. 647, doi. 10.1111/j.1471-0528.1990.tb02558.x
- By:
- Publication type:
- Article
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45714-0
- By:
- Publication type:
- Article
International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study.
- Published in:
- BMC Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10727-3
- By:
- Publication type:
- Article
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 759, doi. 10.1007/s00262-022-03250-0
- By:
- Publication type:
- Article
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor...
- Published in:
- JNCI: Journal of the National Cancer Institute, 1996, v. 88, n. 19, p. 1393, doi. 10.1093/jnci/88.19.1393
- By:
- Publication type:
- Article
Exposure‐response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 7, p. 3182, doi. 10.1111/bcp.15233
- By:
- Publication type:
- Article
Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 5, p. 986, doi. 10.1111/bcp.13889
- By:
- Publication type:
- Article
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-13084-7
- By:
- Publication type:
- Article
Immunotherapy in Urothelial Cancer: Stop When Achieving a Response, Restart upon Disease Progression.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3654, doi. 10.3390/cancers15143654
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1424, doi. 10.3390/cancers13061424
- By:
- Publication type:
- Article
NFκB-Activated COX2/PGE 2 /EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer Tissues.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1323, doi. 10.3390/cancers13061323
- By:
- Publication type:
- Article
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1284, doi. 10.3390/cancers13061284
- By:
- Publication type:
- Article
Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1212, doi. 10.3390/cancers11081212
- By:
- Publication type:
- Article
mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 9, p. 1898, doi. 10.1002/1878-0261.13449
- By:
- Publication type:
- Article
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2086, doi. 10.1002/1878-0261.13196
- By:
- Publication type:
- Article
AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 8, p. 1795, doi. 10.1002/1878-0261.12529
- By:
- Publication type:
- Article
Optimal Control of Acute Cisplatin-lnduced Emesis.
- Published in:
- Oncology, 1996, v. 53, n. S1, p. 56, doi. 10.1159/000227642
- By:
- Publication type:
- Article
Docetaxel in Hormone-Refractory Metastatic Prostate Cancer: A Viewpoint by Ronald de Wit.
- Published in:
- Drugs, 2005, v. 65, n. 16, p. 2295, doi. 10.2165/00003495-200565160-00005
- By:
- Publication type:
- Article
Darolutamide does not interfere with OATP‐mediated uptake of docetaxel.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 2, p. 314, doi. 10.1002/ijc.34922
- By:
- Publication type:
- Article
Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 8, p. 1474, doi. 10.1002/ijc.34810
- By:
- Publication type:
- Article
Antiemetic efficacy of the neurokinin‐1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high‐dose cisplatin: Analysis of combined data from two phase III randomized clinical trials
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 4, p. 864
- By:
- Publication type:
- Article
First results of triple‐modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with Stage IIB, III, and IVA cervical carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 4, p. 763
- By:
- Publication type:
- Article
Overview of bladder cancer trials in the European Organization for Research and Treatment (Based on a Satellite Symposium held in conjunction with the First European Conference on Perspectives in Bladder Cancer, Monte Carlo, Monaco, November 1617, 2001.)
- Published in:
- Cancer (0008543X), 2003, v. 97, p. 2120
- By:
- Publication type:
- Article
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 275, doi. 10.1007/s40801-022-00294-7
- By:
- Publication type:
- Article
Management of intermediate-prognosis germ-cell cancer: Results of a phase I/II study of Taxol-BEP.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 6, p. 831, doi. 10.1002/(SICI)1097-0215(19991210)83:6<831::AID-IJC24>3.0.CO;2-O
- By:
- Publication type:
- Article
Risk of diabetes after para-aortic radiation for testicular cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Loss of SLCO1B3 drives taxane resistance in prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
<sup>68</sup>Ga-PSMA PET/CT for Response Evaluation of <sup>223</sup>Ra Treatment in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1556, doi. 10.2967/jnumed.123.265489
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
68Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article